These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18386192)

  • 1. Radioresistance in a tumour cell line correlates with radiation inducible Ku 70/80 end-binding activity.
    Negroni A; Stronati L; Grollino MG; Barattini P; Gumiero D; Danesi DT
    Int J Radiat Biol; 2008 Apr; 84(4):265-76. PubMed ID: 18386192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and DNA binding activity of the Ku heterodimer in bladder carcinoma.
    Stronati L; Gensabella G; Lamberti C; Barattini P; Frasca D; Tanzarella C; Giacobini S; Toscano MG; Santacroce C; Danesi DT
    Cancer; 2001 Nov; 92(9):2484-92. PubMed ID: 11745306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor specific modulation of KU70/80 DNA binding activity in breast and bladder human tumor biopsies.
    Pucci S; Mazzarelli P; Rabitti C; Giai M; Gallucci M; Flammia G; Alcini A; Altomare V; Fazio VM
    Oncogene; 2001 Feb; 20(6):739-47. PubMed ID: 11314007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of DNA-PKcs and Ku80 individually and in combination: Different effects of radiobiology in HeLa cells.
    Zhuang L; Cao Y; Xiong H; Gao Q; Cao Z; Liu F; Qiu H; Yu S; Huang X
    Int J Oncol; 2011 Aug; 39(2):443-51. PubMed ID: 21573502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Potentials of DNA-PKcs, Ku80, and ATM in enhancing radiosensitivity of cervical carcinoma cells].
    Zhuang L; Yu SY; Huang XY; Cao Y; Xiong HH
    Ai Zheng; 2007 Jul; 26(7):724-9. PubMed ID: 17626748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA-PK-dependent phosphorylation of Ku70/80 is not required for non-homologous end joining.
    Douglas P; Gupta S; Morrice N; Meek K; Lees-Miller SP
    DNA Repair (Amst); 2005 Aug; 4(9):1006-18. PubMed ID: 15941674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitizer effect of wortmannin in radioresistant bladder tumoral cell lines.
    Ortiz T; Lopez S; Burguillos MA; Edreira A; Piñero J
    Int J Oncol; 2004 Jan; 24(1):169-75. PubMed ID: 14654954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA binding activity of Ku during chemotherapeutic agent-induced early apoptosis.
    Iuchi K; Yagura T
    Exp Cell Res; 2016 Mar; 342(2):135-44. PubMed ID: 26976509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The radioprotective effect of the 24 kDa FGF-2 isoform in HeLa cells is related to an increased expression and activity of the DNA dependent protein kinase (DNA-PK) catalytic subunit.
    Ader I; Muller C; Bonnet J; Favre G; Cohen-Jonathan E; Salles B; Toulas C
    Oncogene; 2002 Sep; 21(42):6471-9. PubMed ID: 12226750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary and muscle invasive bladder tumors with distinct genomic stability profiles have different DNA repair fidelity and KU DNA-binding activities.
    Bentley J; L'Hôte C; Platt F; Hurst CD; Lowery J; Taylor C; Sak SC; Harnden P; Knowles MA; Kiltie AE
    Genes Chromosomes Cancer; 2009 Apr; 48(4):310-21. PubMed ID: 19105236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionizing radiation activates IGF-1R triggering a cytoprotective signaling by interfering with Ku-DNA binding and by modulating Ku86 expression via a p38 kinase-dependent mechanism.
    Cosaceanu D; Budiu RA; Carapancea M; Castro J; Lewensohn R; Dricu A
    Oncogene; 2007 Apr; 26(17):2423-34. PubMed ID: 17043647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat inactivation of Ku autoantigen: possible role in hyperthermic radiosensitization.
    Burgman P; Ouyang H; Peterson S; Chen DJ; Li GC
    Cancer Res; 1997 Jul; 57(14):2847-50. PubMed ID: 9230187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated expression of a dominant negative Ku70 fragment radiosensitizes human tumor cells under aerobic and hypoxic conditions.
    He F; Li L; Kim D; Wen B; Deng X; Gutin PH; Ling CC; Li GC
    Cancer Res; 2007 Jan; 67(2):634-42. PubMed ID: 17234773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired telomerase activity in human cells expressing GFP-Ku86 fusion proteins.
    Badie C; Yáñez-Muñoz RJ; Muller C; Salles B; Porter AC
    Cytogenet Genome Res; 2008; 122(3-4):326-35. PubMed ID: 19188702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of DNA repair as a mechanism of enhanced radioresponse of head and neck carcinoma cells by a selective cyclooxygenase-2 inhibitor, celecoxib.
    Raju U; Ariga H; Dittmann K; Nakata E; Ang KK; Milas L
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):520-8. PubMed ID: 16168844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-DNA complexes containing DNA-dependent protein kinase in crude extracts from human and rodent cells.
    Ting NS; Chan DW; Lintott LG; Allalunis-Turner J; Lees-Miller SP
    Radiat Res; 1999 Apr; 151(4):414-22. PubMed ID: 10190493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockage of Autophagy in C6 Glioma Cells Enhanced Radiosensitivity Possibly by Attenuating DNA-PK-Dependent DSB Due to Limited Ku Nuclear Translocation and DNA Binding.
    Liu C; He W; Jin M; Li H; Xu H; Liu H; Yang K; Zhang T; Wu G; Ren J
    Curr Mol Med; 2015; 15(7):663-73. PubMed ID: 26321753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Ku80 correlates with sensitivities to radiation in cancer cell lines of the head and neck.
    Chang HW; Kim SY; Yi SL; Son SH; Song DY; Moon SY; Kim JH; Choi EK; Ahn SD; Shin SS; Lee KK; Lee SW
    Oral Oncol; 2006 Nov; 42(10):979-86. PubMed ID: 16472552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-strand break repair by Ku70 requires heterodimerization with Ku80 and DNA binding functions.
    Jin S; Weaver DT
    EMBO J; 1997 Nov; 16(22):6874-85. PubMed ID: 9362500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ku protein targeting by Ku70 small interfering RNA enhances human cancer cell response to topoisomerase II inhibitor and gamma radiation.
    Ayene IS; Ford LP; Koch CJ
    Mol Cancer Ther; 2005 Apr; 4(4):529-36. PubMed ID: 15827325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.